Physician
Blue Ridge Medical Management Corporation
Blue Ridge Medical Management Corporation was paid $2.81M by Medicaid between Jan 2018 and Dec 2024, across 29 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoBLUE RIDGE MEDICAL MANAGEMENT CORPORATION
ELIZABETHTON, TN 37643
ELIZABETHTON, TN 37643
33aNPI1467833673assigned 06/12/2015
33bProvider typeInternal Medicine Physician
28Total paid$2.81M
24GClaims93,265
24DCodes billed29
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Tennessee
Rank by total paid#11 of 581
Median peer was paid$15K
This provider vs. median186×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KILGORE, CARL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,673 | $156K | |
| 2019 | 3,128 | $96K | |
| 2020 | 3,155 | $85K | |
| 2021 | 12,780 | $591K | |
| 2022 | 23,791 | $661K | |
| 2023 | 22,126 | $514K | |
| 2024incomplete | 23,612 | $705K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 24,573 | 20,979 | $1.03M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 19% | 5,152 | 4,030 | $534K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 7,196 | 5,981 | $391K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 9.6% | 9,563 | 7,856 | $270K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.5% | 4,944 | 4,066 | $211K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 6.4% | 2,493 | 1,834 | $180K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.5% | 3,709 | 3,045 | $70K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.5% | 753 | 669 | $41K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,983 | 2,662 | $21K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,783 | 1,320 | $21K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 485 | 437 | $18K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 290 | 248 | $11K |
17 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 101 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 14 | $1K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 73 | $1K |
| 99201 | <1% | 31 | $974.65 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 25 | $769.65 |
| 87634 | <1% | 37 | $598.98 | |
| 3074F | <1% | 13,349 | $200.00 | |
| 3079F | <1% | 2,010 | $175.00 | |
| 81003 | <1% | 74 | $137.82 | |
| 3078F | <1% | 11,009 | $100.00 | |
| 3075F | <1% | 1,003 | $75.00 | |
| 81002 | <1% | 57 | $35.84 | |
| 3077F | <1% | 368 | $25.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 21 | $12.92 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 14 | $6.37 |
| 3080F | 0% | 74 | $0.00 | |
| 4010F | 0% | 81 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKILGORE, CARL (PRESIDENT)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.